FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3889511000001109: ReQuip tablets follow on pack (GlaxoSmithKline) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17990701000001114 ReQuip tablets follow on pack (GlaxoSmithKline) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
58170601000001110 ReQuip tablets follow on pack (GlaxoSmithKline UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
ReQuip tablets follow on pack (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
ReQuip tablets follow on pack (GlaxoSmithKline) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
ReQuip tablets follow on pack (GlaxoSmithKline) Is a Generic ReQuip tablets follow on pack true Inferred relationship Existential restriction modifier
ReQuip tablets follow on pack (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
ReQuip tablets follow on pack (GlaxoSmithKline) Has excipient Lactose false Inferred relationship Existential restriction modifier
ReQuip tablets follow on pack (GlaxoSmithKline) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
ReQuip tablets follow on pack (GlaxoSmithKline) VMP prescribing status (attribute) Never valid to prescribe as a VMP true Inferred relationship Existential restriction modifier
ReQuip tablets follow on pack (GlaxoSmithKline) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
ReQuip tablets follow on pack (GlaxoSmithKline) Has active ingredient Ropinirole hydrochloride true Inferred relationship Existential restriction modifier
ReQuip tablets follow on pack (GlaxoSmithKline) Has manufactured dose form Dose form not applicable (qualifier value) false Inferred relationship Existential restriction modifier
ReQuip tablets follow on pack (GlaxoSmithKline) Is a ReQuip true Inferred relationship Existential restriction modifier
ReQuip tablets follow on pack (GlaxoSmithKline) Has dispensed dose form Dose form not applicable (qualifier value) false Inferred relationship Existential restriction modifier
ReQuip tablets follow on pack (GlaxoSmithKline) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
ReQuip tablets follow on pack (GlaxoSmithKline) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
ReQuip tablets follow on pack (GlaxoSmithKline) Has dispensed dose form Dose form not applicable (qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
ReQuip tablets follow on pack (GlaxoSmithKline) 147 tablet 1 x (42tabs + 42tabs + 63tabs) Is pack of False ReQuip tablets follow on pack (GlaxoSmithKline) Inferred relationship Existential restriction modifier
ReQuip tablets follow on pack (GlaxoSmithKline) 147 tablet 1 x (42tabs + 42tabs + 63tabs) Has AMP True ReQuip tablets follow on pack (GlaxoSmithKline) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start